Iranian Red Crescent Medical Journal Iran Red Crescent Med J 2011; 13(10):744-745 ©Iranian Red Crescent Medical Journal LETTER TO THE EDITOR Five Years Allograft Survival of Renal Transplants: A Single Center Study

Renal transplantation is the treatment of choice for vast majority of patients with end-stage renal disease.1 Marked improvements in early graft survival and graft function have resulted in kidney transplantation being a cost-effective alternative to dialysis.2 Among the most age groups and etiologies of end-stage renal dis-ease, renal transplantation prolongs patient lifespan.3,4 Accordingly in this study, short and long-term follow ups of patients undergoing kidney transplant were evaluated in a thirteen-year cohort study. In this cohort study, 306 consecutive patients (age from 11 to 66 years) with end-stage renal disease (ESRD) between 1995 and 2008 attending to our in-stitution were recruited. They were selected in a cen-sus manner. Procedure of surgery was usually per